Newsletter
Contact
Careers
Calendar
RFP
Français
myGAVI
Donate
Home
About the Alliance
Learn more about GAVI
GAVI's mission
What we do
GAVI's impact
Challenges and opportunities
Healthy girls, healthy women
Gender and immunisation
Why invest in GAVI?
Advocates
GAVI's strategy
Value of vaccination
GAVI's partnership model
GAVI's business model
Global health and development
Governing GAVI
GAVI Board
GAVI Secretariat
GAVI Internal Audit
Programmatic and Finance Policies
Corporate Policies
Types of support
What GAVI offers and how it works
Apply for support
New and underused vaccines support
Human papillomavirus vaccine
Injection safety support
Measles second dose
Meningitis A vaccine
Pentavalent vaccine
Pneumococcal vaccine
Measles-Rubella vaccine
Rotavirus vaccine
Yellow fever vaccine
Immunisation services support
Health Systems Funding Platform
Health system strengthening
Civil society organisation
Country hub
Afghanistan
Albania
Angola
Armenia
Azerbaijan
Bangladesh
Benin
Bhutan
Bolivia
Bosnia & Herzegovina
Burkina Faso
Burundi
Cambodia
Cameroon
Central African Republic (the)
Chad
China
Comoros
Congo
Congo, DR
Côte d’Ivoire
Cuba
Djibouti
Eritrea
Ethiopia
Gambia
Georgia
Ghana
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
India
Indonesia
Kenya
Kiribati
Korea, DPR
Kyrgyzstan
Lao PDR
Lesotho
Liberia
Madagascar
Malawi
Mali
Mauritania
Moldova
Mongolia
Mozambique
Myanmar
Nepal
Nicaragua
Niger
Nigeria
Pakistan
Papua New Guinea
Rwanda
Sao Tome and Principe
Senegal
Sierra Leone
Solomon Islands
Somalia
South Sudan
Sri Lanka
Sudan
Tajikistan
Tanzania, UR
Timor Leste
Togo
Turkmenistan
Uganda
Ukraine
Uzbekistan
Vietnam
Yemen
Zambia
Zimbabwe
Funding & finance
Long-term financial commitments
How GAVI is funded
Key figures: donor contributions & pledges
Donor profiles
Financial reports
GAVI Matching Fund
How it works
Partners
International Finance Facility for Immunisation
Pneumococcal AMC
Results & evidence
Measuring & evaluating performance
Goal-level indicators
Mission indicators
Vaccine goal indicators
Health systems goal indicators
Financing goal indicators
Market-shaping goal indicators
Countries approved for support
Disbursements by country
GAVI's evaluation studies
GAVI first evaluation report
GAVI second evaluation report
GAVI support to CSO evaluation
GAVI-Government of China Hepatitis B vaccination programme
Gender Policy evaluation
IFFIm evaluation
Pneumococcal AMC process and design
Other studies
GAVI Progress reports
Library & news
Search by topic, country and programme
News
Press releases
Statements
Return on investment stories
GAVI features
Eyewitness
GAVI blogs
Audio-visual
Board & committee minutes
GAVI documents
Country documents
Evaluations
Financial reports
Guidelines and forms
Policies
Strategy
Supply and procurement
Publications
Events
You are here:
Library
Audio-visual
Audio-visual
Galleries
Galleries
Pentavalent vaccine saves lives in Madagascar
Pentavalent vaccine saves lives in Madagascar
in page functions
Linked to increasing immunisation coverage with vaccines such as the pentavalent, Madagascar is one of just six countries in the world to reduce its child mortality rates by more than 60% between 1990 and 2009.
16 May 2011
Ed Harris/GAVI/2011
An ox and cart pass a health clinic at Ambovombe in southern Madagascar. With 80% of the population living in rural areas and an average annual income per capita of just US$ 410 in 2010, maintaining a functioning health system is a challenge.
Ed Harris/GAVI/2011
A dirt road leads up to the health clinic at Ankariera in southern Madagascar. Many of the women who brought their children for immunisation on 17 May 2011 had walked 18 kilometres, braving cattle-rustlers and bandits.
Ed Harris/GAVI/2011
Hantamalala Ramanandraibe immunises a child with a GAVI-supported vaccine, the pentavalent vaccine, at the health post in Ankariera. Vaccine-preventable diseases kill 1.7 million children every year, accounting for roughly 20% of all under five child mortality.
Ed Harris/GAVI/2011
UNICEF staff in blue t-shirts mingle with visiting journalists and mothers waiting to immunise their children at Ankariera. UNICEF is a key member of the GAVI Alliance, helping them to reduce vaccine prices as the world’s largest purchaser of vaccines for developing countries.
Ed Harris/GAVI/2011
Hantamalala Ramanandraibe checks an immunisation record at a health point in Ankariera. According to WHO / UNICEF data, Madagascar’s immunisation coverage rose to 78% in 2009 from 57% in 2001.
Ed Harris/GAVI/2011
Child sleeps while strapped to its mother’s back at a health point in southern Madagascar before starting the journey home after vaccination with the pentavalent vaccine.
Ed Harris/GAVI/2011
Clarette Raharimanjaka, a midwife, holds up a vial of pentavalent vaccine – “Easyfive” – that protects against five life-threatening diseases – diphtheria, tetanus, pertussis, hepatitis B, and Haemophilus influenzae type B (HiB).
Ed Harris/GAVI/2011
Doctor Hanintsoa Rakotoarimanga checks a mother’s immunisation record before giving the pentavalent vaccine at a health point in Isotry, a district of Madagascar’s capital, Antananarivo.
Ed Harris/GAVI/2011
Eulalie Rasoarlalao and her four-month-old baby girl, Francia, smile for the camera following immunisation at a health point in Isotry, Antananarivo.
Related Library items
Dagfinn Høybråten's blog
Search keywords
Madagascar
pentavalent
modal window here